Numeric Investors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Numeric Investors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,326	Closed	-$253K	–	1185
2016 Q4	$253K	Buy	+2,326	New	+$277K	﹤0.01%	961
2015 Q4	–	Sell	-3,300	Closed	-$547K	–	1158
2015 Q3	$547K	Buy	+3,300	New	+$726K	0.01%	681
2014 Q4	–	Sell	-6,600	Closed	-$1.56M	–	1002
2014 Q3	$1.56M	Buy	6,600 +4,080	+162%	+$1.04M	0.02%	365
2014 Q2	$596K	Buy	2,520 +1,170	+87%	+$308K	0.01%	538
2014 Q1	$445K	Buy	+1,350	New	+$456K	0.01%	614
2013 Q4	–	Sell	-33,942	Closed	-$2.34M	–	908
2013 Q3	$2.34M	Buy	+33,942	New	+$1.68M	0.04%	317

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Numeric Investors's ICPT Position: Q1 2017 in Review

Numeric Investors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2017, closing a stake of 2,326 shares — an estimated $253K sold.

Numeric Investors first reported a position in ICPT in Q3 2013 and held it in 6 quarters. The position peaked at $2.34M in Q3 2013. 150 funds tracked by Wall St. Rank hold ICPT as of Q1 2017.

Numeric Investors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Numeric Investors sold 2,326 Intercept Pharmaceuticals, Inc. shares in Q1 2017, an estimated $253K.
Numeric Investors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
Numeric Investors's Intercept Pharmaceuticals, Inc. position peaked at $2.34M in Q3 2013.
150 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.